194: Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial
K. P. Lui, K. Wang, R. C. Chen, B. L. Kane, C. A. Medbery III, K. Underhill Jr, J. R. Gray, A. V. Peddada, and D. B. Fuller | ASTRO | 2022
2026: Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy
P.S. Sridhar, P. Anuradha, C. Fareena Taj, S. Suresh, K. Roopesh, R. Ghosh, S. Bj, | ASTRO | 2022
Hypofractionated Stereotactic Radiotherapy with or without Whole Brain Radiotherapy with Helical Tomotherapy for Multiple Brain Metastases – Long-Term Follow-Up Results of a Phase II Trial
Yuchao Ma | ASTRO | 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
Optimized Conformal Total Body Irradiation methods with Helical TomoTherapy and Elekta VMAT: Implementation, Imaging, Planning and Dose Delivery for Pediatric Patients
Loginova AA, Tovmasian DA, Lisovskaya AO, Kobyzeva DA, Maschan MA, Chernyaev AP, Egorov OB, and Nechesnyuk AV | Front Oncol | 2022
ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children
Hoeben BAW, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH, Boterberg T, Ospovat I, Mico Milla S, Abakay CD, Engellau J, Johansson V, Kos G, Supiot S, Llagostera C, Bierings M, Scarzello G, Seiersen K, Smith E, Ocanto A, Ferrer C, Bentzen SM, Kobyzeva DA, Loginova AA, and Janssens GO | Radiother Oncol […]
Influencing Factors of Total Skin Irradiation With Helical Tomotherapy
Wang H, Pi Y, Guo Y, Pei X, and Xu XG | Front Oncol | 2022
Pediatric Craniospinal Irradiation – The implementation and Use of Normal Tissue Complication Probability in Comparing Photon versus Proton Planning
Balasubramanian S, and Shobana MK | J Med Phys | 2022
Technical Note: Comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws
Chen GP, Tai A, Keiper TD, Lim S, Li XA | Med Phys | 2020
Characterization of imaging performance of a novel helical kVCT for use in image-guided and adaptive radiotherapy – PubMed (nih.gov)
Tegtmeier RC, Ferris WS, Bayouth JE, Miller JR, and Culberson WS | J Appl Clin Med Phys | 2022
Robotic CyberKnife radiosurgery for small choroidal melanomas – PubMed (nih.gov)
Valerie Schmelter, Theresa Hofmann, Frederick Schneider, Constance Weber, Christoph Fuerweger, Alexander Muacevic, Siegfried G Priglinger, Paul Foerster, Raffael Liegl | Melanoma Res | 2022
Feasibility of postoperative spine stereotactic body radiation therapy in proximity of carbon and titanium hybrid implants using a robotic radiotherapy device
Dominik Henzen, Daniel Schmidhalter, Gian Guyer, Anna Stenger-Weisser, Ekin Ermiş, Robert Poel, Moritz Caspar Deml, Michael Karl Fix, Peter Manser, Daniel Matthias Aebersold, Hossein Hemmatazad | Radiat Oncol | 2022
The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy
Cheng YK, Kuo SH, Yen HH, Wu JH, Chen YC, and Huang MY | Radiat Oncol | 2022
Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer – PubMed (nih.gov)
Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, and Yin Y | Oncol Lett | 2022
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
Ferrera G, D’Alessandro S, Cuccia F, Serretta V, Trapani G, Savoca G, Mortellaro G, Lo Casto A | J Cancer Res Clin Oncol | 2022
Moderate Hypofractionated Helical TomoTherapy for Older Patients with Localized Prostate Cancer: Long-term Outcomes of a Phase I-II Trial
Cui D, Du L, Yu W, Cai B, Meng L, Yang J, Luo Y, Chen J, and Ma L | Radiol Oncol| 2022
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer – PubMed (nih.gov)
Shi Z, Yang J, Kong W, Qiu X, Lu C, Liu J, Liu B, and Du J | Front Oncol | 2022
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage
Bae SH, Cho KH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lee MH, Lim S, Jung JH, and Lim SH | Transl Cancer Res | 2022
Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: Single centre experience
Zolcsak Z, Loap P, Fourquet A, and Kirova YM | Cancer Radiother | 2022
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience
Hoeben BAW, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH, Boterberg T, Ospovat I, Mico Milla S, Abakay CD, Engellau J, Johansson V, Kos G, Supiot S, Llagostera C, Bierings M, Scarzello G, Seiersen K, Smith E, Ocanto A, Ferrer C, Bentzen SM, Kobyzeva DA, Loginova AA, and Janssens GO | Clin Transl […]
